Back
Fidus Investment 10K Form
Buy
57
FDUS
Fidus Investment
Last Price:
21.40
Seasonality Move:
4.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | FDUS/Fidus Investment Quarterly |
2023-11-02 | 10Q | FDUS/Fidus Investment Quarterly |
2023-08-03 | 10Q | FDUS/Fidus Investment Quarterly |
2023-05-04 | 10Q | FDUS/Fidus Investment Quarterly |
2022-11-03 | 10Q | FDUS/Fidus Investment Quarterly |
2022-08-04 | 10Q | FDUS/Fidus Investment Quarterly |
Receive FDUS News And Ratings
See the #1 stock for the next 7 days that we like better than FDUS
FDUS Financial Statistics
Sales & Book Value
Annual Sales: | $88M |
---|---|
Cash Flow: | $4.68M |
Price / Cash Flow: | 0 |
Annual Sales: | $19.42 |
Price / Book: | 1.11 |
Profitability
EPS (TTM): | 2.83000 |
---|---|
Net Income (TTM): | $87.13M |
Gross Margin: | $65.06M |
Return on Equity: | 14.27% |
Return on Assets: | 7.9% |
Fidus Investment Earnings Forecast
Key Fidus Investment Financial Ratios
- The Gross Profit Margin over the past 10 years for FDUS is 114.40%.
- The Selling, General & Administrative Expenses for FDUS have been equal to 7.15% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 26.21% of Operating Income.
- The Net Earning history of FDUS is 87.65% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 9 years.
Fidus Investment Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | FDUS |
CUSIP: | 316500 |
Website: | fdus.com |
Debt
Debt-to-Equity Ratio: | 0.72 |
---|---|
Current Ratio: | 2.28 |
Quick Ratio: | 2.23 |
Price-to-Earnings
Trailing P/E Ratio: | 7.33 |
---|---|
Forward P/E Ratio: | 10.2 |
FDUS Technical Analysis vs Fundamental Analysis
Buy
57
Fidus Investment (FDUS)
is a Buy
Is Fidus Investment a Buy or a Sell?
-
Fidus Investment stock is rated a Buy
The current Fidus Investment [FDUS] share price is $21.49. The Score for FDUS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.